VF
MIST icon

Virtu Financial’s Milestone Pharmaceuticals MIST Stock Holding History

Virtu Financial’s Portfolio MIST Stock Details MIST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$16K Buy
+11,613
New +$18.6K ﹤0.01% 1376
2025
Q3 		– Sell
-14,761
Closed -$29K – 1840
2025
Q2 		$29K Buy
+14,761
New +$19.7K ﹤0.01% 1212
2025
Q1 		– Sell
-71,955
Closed -$170K – 1770
2024
Q4 		$170K Buy
+71,955
New +$124K 0.01% 925
2024
Q1 		– Sell
-18,686
Closed -$31K – 1814
2023
Q4 		$31K Buy
+18,686
New +$50.7K ﹤0.01% 1247
2023
Q3 		– Sell
-11,743
Closed -$33K – 1647
2023
Q2 		$33K Buy
+11,743
New +$44.3K ﹤0.01% 1186
2023
Q1 		– Sell
-15,774
Closed -$62K – 1847
2022
Q4 		$62K Buy
+15,774
New +$83K 0.01% 1044

Other funds holding MIST

PCM
Pavaki Capital Management Pueblo, Colorado $287M AUM
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
PBM
Propel Bio Management Los Angeles, California $191M AUM 102.42% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $174M AUM
LPC
Lion Point Capital New York $20.9M AUM 195.52% 1-Year Est. Return

Virtu Financial's MIST Position: Q2 2026 in Review

Virtu Financial opened a new position in Milestone Pharmaceuticals (MIST) in Q2 2026: 11,613 shares worth $16K. The stake represents ﹤0.01% of the portfolio and ranks #1376 among its holdings. This is a return to the name: Virtu Financial previously reported a position in MIST as recently as Q2 2025.

Virtu Financial first reported a position in MIST in Q4 2022 and has held it in 6 quarters since. The position peaked at $170K in Q4 2024. 78 funds tracked by Wall St. Rank hold MIST as of Q2 2026.

  • Virtu Financial held 11,613 shares of Milestone Pharmaceuticals worth $16K as of Q2 2026.
  • Milestone Pharmaceuticals was a new Virtu Financial position in Q2 2026.
  • Milestone Pharmaceuticals made up ﹤0.01% of Virtu Financial's portfolio in Q2 2026, its #1376 holding.
  • Virtu Financial first reported a position in Milestone Pharmaceuticals in Q4 2022 and has held it in 6 quarters since.
  • Virtu Financial's Milestone Pharmaceuticals position peaked at $170K in Q4 2024.
  • 78 funds tracked by Wall St. Rank held Milestone Pharmaceuticals as of Q2 2026.

Based on Virtu Financial's 13F filing for Q2 2026, filed 13 Aug 2026.